Menu

Expanded Access Programs (EAPs), sometimes known as Managed Access Programmes (MAPs), allow pharmaceutical sponsors to offer patients their pre-approval investigational

For years, the prospect of ‘virtual’ and decentralised research was discussed with hope as a potential disruptor to enable greater

Cisiv partnered with a specialist CRO and a Medical Device Company (IVD Sponsor) to conduct an end-to-end process for clinical
To find out more about the Cisiv technology and how we can help you with your study.